Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05276713
Status:
UNKNOWN
Last Update Posted:
2022-03-11
First Post:
2022-03-03
Brief Title:
Outcome of Tucidinostat-Based Therapy in HR Metastatic Breast Cancer Patients Previously Treated With CDK46 Inhibitor
Sponsor:
Beijing 302 Hospital
Organization:
Beijing 302 Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-03
First Submit QC Date:
March 3 2022
Study First Post Date:
2022-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-03
Last Update Post Date:
2022-03-11
Last Update Post Date Type:
ACTUAL